Collaboration is Key to Microbiomics: New Deal with The Janssen Human Microbiome Institute

07/01/2016 - 3 minutes

The Janssen Human Microbiome Institute, the French National Institute for Agricultural Research (INRA) and Johnson & Johnson Innovation AND Takeda are signing up to collaborate with the Paris biotech Enterome to help accelerate Microbiomics research into Crohn’s Disease.

The collaboration is based on initial findings by the INRA showing that some commensal (symbiotic) bacteria elicit anti-inflammatory effects in the human gut. And since then, the Microbiome field has really taken off globally, particularly with the launch of the World first Microbiome fund by Seventure.

Then Novartis jumped on board, swelling the pot to over €160M…and everyone wanted to talk about it, especially given the increasing awareness surrounding the breakthrough application of Microbiomics into other hyped therapeutic fields such as Immuno-Oncology (at the Gustave-Roussy Institute).


There is even an increased focus in Next-Generation Sequencing specialists, such as the US leader in genomics,

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!